The New Political Economy of Pharmaceuticals

Production, Innovation and TRIPS in the Global South

  • Hans Löfgren
  • Owain David Williams

Part of the International Political Economy Series book series (IPES)

Table of contents

  1. Front Matter
    Pages i-xvi
  2. Dina Iskander
    Pages 91-110
  3. Sudip Chaudhuri
    Pages 111-133
  4. Richard Husada, Raymond R. Tjandrawinata
    Pages 134-151
  5. Mohamed Azmi Hassali, Jayabalan Thambyappa, Shankaran Nambiar, Asrul Akmal Shafie, Hans Löfgren
    Pages 152-166
  6. Zaheer-Ud-Din Babar, Shazia Qasim Jamshed, Muhammad Ashar Malik, Hans Löfgren, Anwarul-Hassan Gilani
    Pages 167-184
  7. Andrew L. Gray, Yousuf A. Vawda
    Pages 185-203
  8. Bong-min Yang, Hye-young Kwon
    Pages 204-220
  9. Hans Löfgren, Owain David Williams
    Pages 246-250
  10. Back Matter
    Pages 251-265

About this book


Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. This volume is the first cross-country analysis of how TRIPS has affected the capacity of 11 major low or medium income countries to produce generic drugs.


economy health policy Policy political economy

Editors and affiliations

  • Hans Löfgren
    • 1
  • Owain David Williams
    • 2
  1. 1.School of Humanities and Social SciencesDeakin UniversityAustralia
  2. 2.Centre for Health and International RelationsAberystwyth UniversityUK

Bibliographic information

Industry Sectors
Finance, Business & Banking